Abstract Abstract The European Society of Cardiology 2021 guideline on cardiovascular
(CV) disease (CVD) prevention in clinical practice has major implications for both CV risk …

Chronic kidney disease (CKD) affects over 850 million people globally, and there is an
urgent need to prevent its development and progression. During the last decade, new …

Importance Chronic kidney disease (low estimated glomerular filtration rate [eGFR] or
albuminuria) affects approximately 14% of adults in the US. Objective To evaluate …

Importance Albuminuria testing is crucial for guiding evidence-based treatments to mitigate
chronic kidney disease (CKD) progression and cardiovascular morbidity, but it is widely …

This article is published as part of a supplement sponsored by Kidney Disease: Improving
Global Outcomes (KDIGO). The opinions or views expressed in this supplement are those of …

Background Chronic kidney disease (CKD) has a rising global prevalence and is expected
to become the fifth leading cause of death by 2030. Increased albuminuria defines the early …

Abstract SCREAM (Stockholm CREAtinine Measurements project) was initiated in 2010 in
collaboration with the healthcare provider of Stockholm County healthcare to quantify …

Chronic kidney disease (CKD) is projected to become a leading global cause of death by
2040, and its early detection is critical for effective and timely management. The current …

The availability of electronic health records and access to a large number of routine
measurements of serum creatinine and urinary albumin enhance the possibilities for …

Objectives To compare the validity and robustness of five methods for handling missing
characteristics when using cardiovascular disease risk prediction models for individual …